K4 Elite
A peptide-complex bioregulator derived from brain tissue, studied in Russian gerontology literature for proposed neuronal and geroprotective effects.
Cerluten is a 'cytomax' peptide bioregulator in the Khavinson tradition, described as a complex of short peptides extracted from the brain tissue of young animals. Within this framework it is grouped with tissue-specific preparations proposed to act on the organ system of origin.
The literature associates Cerluten with the central nervous system and positions it among geroprotective peptide complexes studied for effects on neuronal function during aging. As a tissue-derived complex rather than a single defined molecule, it has no consistently reported structure or PubChem identifier.
Molecular fields are therefore left blank. The summary below reflects the available scientific literature for reference purposes only.
The Khavinson-school hypothesis holds that short peptides in these complexes bind regulatory DNA sequences and modulate tissue-specific gene expression, with Cerluten proposed to influence neuronal tissue. Reported laboratory work describes effects on neuronal survival markers and antioxidant parameters.
These mechanistic accounts derive mainly from the developing research group and remain hypotheses under active investigation rather than independently established pathways.
Khavinson and colleagues have reported animal studies of brain-derived peptide complexes, describing changes in neuronal markers, oxidative-stress measures, and survival parameters in aging models. These are summarized strictly as published exploratory findings from a single research school.
Broader review work by Khavinson situates Cerluten within the cytomax peptide framework alongside other tissue bioregulators, describing proposed geroprotective activity observed in laboratory settings rather than in controlled independent trials.
Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.